Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

33 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
In Vivo Induction of Leukemia-Specific Adaptive and Innate Immune Cells by Treatment of AML-Diseased Rats and Therapy-Refractory AML Patients with Blast Modulating Response Modifiers.
Atzler M, Baudrexler T, Amberger DC, Rogers N, Rabe A, Schmohl J, Wang R, Rank A, Schutti O, Hirschbühl K, Inngjerdingen M, Deen D, Eiz-Vesper B, Schmid C, Schmetzer HM. Atzler M, et al. Among authors: schmohl j. Int J Mol Sci. 2024 Dec 16;25(24):13469. doi: 10.3390/ijms252413469. Int J Mol Sci. 2024. PMID: 39769232 Free PMC article.
Dendritic/antigen presenting cell mediated provision of T-cell receptor gamma delta (TCRγδ) expressing cells contributes to improving antileukemic reactions ex vivo.
Rackl E, Hartz A, Aslan Rejeski H, Li L, Klauer LK, Ugur S, Pepeldjiyska E, Amend C, Weinmann M, Doraneh-Gard F, Stein J, Reiter N, Seidel CL, Plett C, Amberger DC, Bojko P, Kraemer D, Schmohl J, Rank A, Schmid C, Schmetzer HM. Rackl E, et al. Among authors: schmohl j. Mol Immunol. 2024 Nov;175:40-54. doi: 10.1016/j.molimm.2024.09.007. Epub 2024 Sep 20. Mol Immunol. 2024. PMID: 39305847 Free article.
Granulocyte-Macrophage-Colony-Stimulating-Factor Combined with Prostaglandin E1 Create Dendritic Cells of Leukemic Origin from AML Patients' Whole Blood and Whole Bone Marrow That Mediate Antileukemic Processes after Mixed Lymphocyte Culture.
Unterfrauner M, Rejeski HA, Hartz A, Bohlscheid S, Baudrexler T, Feng X, Rackl E, Li L, Rank A, Filippini Velázquez G, Schmid C, Schmohl J, Bojko P, Schmetzer H. Unterfrauner M, et al. Among authors: schmohl j. Int J Mol Sci. 2023 Dec 13;24(24):17436. doi: 10.3390/ijms242417436. Int J Mol Sci. 2023. PMID: 38139264 Free PMC article.
Dendritic Cell-Triggered Immune Activation Goes along with Provision of (Leukemia-Specific) Integrin Beta 7-Expressing Immune Cells and Improved Antileukemic Processes.
Rackl E, Li L, Klauer LK, Ugur S, Pepeldjiyska E, Seidel CL, Gunsilius C, Weinmann M, Doraneh-Gard F, Reiter N, Plett C, Amberger DC, Bojko P, Kraemer D, Schmohl J, Rank A, Schmid C, Schmetzer HM. Rackl E, et al. Among authors: schmohl j. Int J Mol Sci. 2022 Dec 27;24(1):463. doi: 10.3390/ijms24010463. Int J Mol Sci. 2022. PMID: 36613907 Free PMC article.
Immunomodulatory kits generating leukaemia derived dendritic cells do not induce blast proliferation ex vivo: IPO-38 as a novel marker to quantify proliferating blasts in acute myeloid leukaemia.
Plett C, Klauer LK, Amberger DC, Ugur S, Rabe A, Fischer Z, Deen D, Hirn-Lopez A, Gunsilius C, Werner JO, Schmohl J, Krämer D, Rank A, Schmid C, Schmetzer HM. Plett C, et al. Among authors: schmohl j. Clin Immunol. 2022 Sep;242:109083. doi: 10.1016/j.clim.2022.109083. Epub 2022 Jul 28. Clin Immunol. 2022. PMID: 35908638
33 results